Research update - Articles | CARLAT PUBLISHING

RESEARCH UPDATE

Comparing Side Effect Sizes With a Free New Tool

June 1, 2025

Kamron Fariba, MD. Dr. Fariba has no financial relationships with companies related to this material.

A new digital tool helps clinicians compare psychiatric medications based on side effect profiles—streamlining complex decisions with data from dozens of major studies and treatment guidelines.

RESEARCH UPDATE

Mirtazapine and B6 Outperform Propranolol for Akathisia

June 1, 2025

Steven Hamilton, PhD, MD

Steven Hamilton, PhD, MD.

Dr. Hamilton has no financial relationships with companies related to this material.

Researchers compares treatments for antipsychotic-induced akathisia, highlighting options that may offer relief with fewer side effects.

RESEARCH UPDATE

Repurposing Antinausea Medications for OCD

June 1, 2025

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial conflicts with companies related to this material.

ECT in Clozapine-Resistant Schizophrenia

May 1, 2025

Simon M. Dosovitz, MD

Simon M. Dosovitz, MD.

Dr. Dosovitz has no financial relationships with companies related to this material.

It’s difficult to find options when clozapine does not work.

VMAT-2 Inhibitors Potentially Help Psychosis

May 1, 2025

Ivy Song, MD

Ivy Song, MD. Dr. Song has no financial relationships with companies related to this material.

Research Update

Long-Term Cardiovascular Risks of ADHD Medications: A Closer Look

April 1, 2025

Joshua Feder, MD

Josh Feder, MD. Dr. Feder has no financial relationships with companies related to this material.

We know that stimulant medications for ADHD can reduce chronic health conditions and extend healthy years for patients. But are there cardiovascular risks from these or non-stimulant medications used for ADHD? In this research update, we review a study that helps clarify the risks of long term use in youth and adults.

Enhancing Antidepressant Efficacy in Older Adults

April 1, 2025

Jaime A.B. Wilson, PhD, ABN

Jaime A.B. Wilson, PhD, ABN. Dr. Wilson has no financial relationships with companies related to this material.

It’s not just finding the antidepressant—dose, duration, and augmentation strategies matter.

Research Update

Some Antidepressants May Help Longer Than Others

April 1, 2025

Jeremy Mills, DNP, PMHNP-BC

Jeremy Mills, DNP, PMHNP-BC. Dr. Mills has no financial relationships with companies related to this material.

A large Danish study ranks antidepressants by their preventative effects.

Research Update

Proposed Treatment Algorithm for Postpartum Psychosis

March 1, 2025

Alex Evans, PharmD, MBA.

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

Zuranolone (Zurzuvae) may be FDA-approved for postpartum depression, but we need a very different medication approach for the 1-2 in 1,000 who develop postpartum psychosis.